Posts by: Margarida Azevedo, MSc

Margarida Azevedo, MSc

Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.

October 27, 2016October 27, 2016

Switch to Biosimilar Inflectra from Remicade Supported by Report at 2016 UEG Week

News

Phase 4 trial results were recently presented that supported switching patients from Remicade (infliximab) to its biosimilar drug Inflectra as a safe and non-inferior alternative. The results, presented at the UEG (United European Gasroenterology) Week 2016 in ... Read more

October 26, 2016February 28, 2017

Stop Saying Surgery Will Cure Everything

Columns, Crohn's Corner - a column by Judy Walters

Today, a well-meaning friend told me I must be tempted to have surgery, because a friend of hers with Crohn’s had a colostomy two years ago and now doesn’t have Crohn’s anymore. ... Read more

October 25, 2016

Extracellular Vesicles at Core of Project to Treat Perianal Fistulas in Crohn’s Disease

News

Esperite’s R&D Division The Cell Factory is working with the Women’s and Children’s Health Department of the University of Padua and the Padua University Hospital in Italy on a innovative ... Read more

October 24, 2016

Adults Diagnosed with IBD as Kids Attain Higher Education Levels than Healthy People, Study Suggests

News

Adults diagnosed with inflammatory bowel disease (IBD) in childhood appear to achieve higher education levels compared to those without the disease, new research shows. The finding should offer hope to children with IBD and ... Read more

October 21, 2016October 21, 2016

German Program Aims to Help Young IBD Patients Move Safely to Adult Care

News

A new way of transitioning pediatric inflammatory bowel disease (IBD) patients to adult care — known as the Berliner Transitions Programme (BTP) — is being presented as way to improve patient quality of life by focusing ... Read more

October 19, 2016December 16, 2016

Changing Treatments

Columns, Crohn's Corner - a column by Judy Walters

As I mentioned in my first post last week, I’m a Crohn’s disease veteran, with more than 15 years of fighting under my belt. I’ve tried many different kinds of treatments ... Read more

October 17, 2016

Asana Reports Positive Preclinical Data of Treatment for Ulcerative Colitis

News

Asana Medical has announced positive data from a preclinical study using an innovative liquid treatment called Extracellular Matrix Hydrogel (ECMH) for the treatment of ulcerative colitis (UC) and other gastrointestinal diseases. ... Read more

October 14, 2016

Data on Kappaproct for Ulcerative Colitis to be Presented at 2016 United European Gastroenterology Week

News

InDex Pharmaceuticals will present additional data from its trial that investigated Kappaproct (cobitolimod) for treatment of moderate to severe active ulcerative colitis (UC). The data will be presented by Raja Atreya, ... Read more

October 13, 2016

Prometheus Validates Anser VDZ Assay for Use in IBD Patients

Crohn's Disease, News

Prometheus Laboratories has validated its novel Prometheus Anser VDZ assay to monitor adult patients with inflammatory bowel diseases (IBD), including patients with moderate-to-severe active ulcerative colitis (UC) and Crohn’s disease ... Read more

October 11, 2016

Symptoms of Ulcerative Colitis May Continue Even After Mucosal Healing

News

Researchers at Icahn School of Medicine at Mount Sinai found that up to one-third of patients with ulcerative colitis who achieve mucosal healing still experience increased stool frequency, and suggest that its underlying cause could be ... Read more